Atlas Trials

A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2

Clinical trial NCT03203421 · COMPLETED

Trial details

NCT number
NCT03203421
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malaria
Start date
2017-07-03
Primary completion
2017-12-20
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.